The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toxicity profile and discordance between patients/physicians regarding niraparib maintenance in recurrent ovarian cancer (ROC) patients: Lessons from the NIQOLE real-life study—GINECO study.
 
Florence Joly
Consulting or Advisory Role - 3A Pharmaceuticals & Diagnostics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; BMS; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology
 
Elsa Kalbacher
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; Leo Pharma
Research Funding - AstraZeneca; Eisai; GlaxoSmithKline; Leo Pharma
Travel, Accommodations, Expenses - AstraZeneca; Eisai; GlaxoSmithKline; Leo Pharma
 
Delphine Garbay Decoopman
No Relationships to Disclose
 
Yaelle Ouldbey
No Relationships to Disclose
 
Philippe Follana
Consulting or Advisory Role - AZTherapies; Clovis Oncology; Daiichi Sankyo Pharmaceutical; GlaxoSmithKline; Lilly O.; MSD; Novartis
Expert Testimony - AZTherapies; Clovis Oncology; Daiichi Sankyo Pharmaceutical; GlaxoSmithKline; Lilly O.; MSD; Novartis
Travel, Accommodations, Expenses - AZTherapies; Clovis Oncology; Daiichi Sankyo Pharmaceutical; GlaxoSmithKline; Lilly O.; MSD; Novartis
 
Heba Dawood
No Relationships to Disclose
 
Eric Legouffe
No Relationships to Disclose
 
Pierre-Emmanuel Brachet
No Relationships to Disclose
 
Dominique Spaeth
Honoraria - Janssen; Novartis; Roche/Genentech
Consulting or Advisory Role - Lilly; Novartis
 
Pierre Combe
No Relationships to Disclose
 
Anne-Claire Hardy-Bessard
Consulting or Advisory Role - AstraZeneca; AstraZeneca/Daiichi Sankyo; Clovis Oncology; Eisai; GlaxoSmithKline; Novartis; Pfizer; Seagen
 
Frédéric Selle
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; MSD; Sandoz
Consulting or Advisory Role - AstraZeneca; MSD
Speakers' Bureau - AstraZeneca; GlaxoSmithKline/Tesaro; MSD
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline/Tesaro; MSD; Roche
 
Julien Grenier
Honoraria - Daiichi Sankyo Pharmaceutical
Other Relationship - Daicel; MSD
 
Coriolan Lebreton
Honoraria - Clovis Oncology; Eisai; GlaxoSmithKline; MSD Oncology
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Olfa Derbel
No Relationships to Disclose
 
Paul Bouheret
No Relationships to Disclose
 
Pierre Fournel
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Bristo-Myers-Squibb; Lilly; MSD Oncology; Pfizer; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Takeda
 
Yolanda Fernandez Diez
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Stanislas Quesada
No Relationships to Disclose
 
Jean Emmanuel Kurtz
Employment - MSD (I)
Honoraria - Clovis Oncology; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Dragonfly Therapeutics; TESARO
Travel, Accommodations, Expenses - PharmaMar; Roche; TESARO